Skip to content

AYTU

Aytu BioPharma, Inc.

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US

$2.21
−3.28%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-2.2%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 30, 2026JAIN ABHINAV · directorA-Award10,000$0.00
Jul 30, 2026LIU VIVIAN H · directorA-Award10,000$0.00
Jul 30, 2026Selhorn Ryan J · officer: Chief Financial OfficerA-Award25,000$0.00
Jul 30, 2026Disbrow Jarrett · officer: Chief Business OfficerA-Award15,000$0.00
Jul 30, 2026PYSZCZYMUKA GREG · officer: Chief Commercial OfficerA-Award20,000$0.00
Jul 30, 2026Disbrow Joshua R. · director, officer: Chief Executive OfficerA-Award30,000$0.00
Jul 30, 2026Donofrio John Jr. · directorA-Award10,000$0.00
Jul 30, 2026DOCKERY CARL · directorA-Award10,000$0.00
Oct 7, 2025Disbrow Joshua R. · director, officer: Chief Executive OfficerA-Award31,446$0.00
Oct 7, 2025LIU VIVIAN H · directorA-Award10,000$0.00
Oct 7, 2025JAIN ABHINAV · directorA-Award10,000$0.00
Oct 7, 2025DOCKERY CARL · directorA-Award10,000$0.00
Oct 7, 2025Donofrio John Jr. · directorA-Award10,000$0.00
Oct 7, 2025PYSZCZYMUKA GREG · officer: Chief Commercial OfficerA-Award12,500$0.00
Oct 7, 2025Disbrow Jarrett · officer: Chief Business OfficerA-Award12,500$0.00
Oct 7, 2025Disbrow Jarrett · officer: Chief Business OfficerA-Award19,606$0.00
Oct 7, 2025Selhorn Ryan J · officer: Chief Financial OfficerA-Award17,500$0.00
Oct 7, 2025Selhorn Ryan J · officer: Chief Financial OfficerA-Award16,243$0.00
Oct 7, 2025Disbrow Joshua R. · director, officer: Chief Executive OfficerA-Award22,500$0.00
Jun 10, 2025Disbrow Jarrett · officer: Chief Business OfficerPurchase16,666$1.50
Jun 10, 2025Disbrow Joshua R. · officer: Chief Executive OfficerPurchase66,666$1.50
Jun 9, 2025Nantahala Capital Management, LLC · 10 percent ownerPurchase4,000,000$0.00
Mar 31, 2025PYSZCZYMUKA GREG · officer: Chief Commercial OfficerM-Exempt209$0.00
Mar 3, 2025Disbrow Joshua R. · officer: Chief Executive OfficerPurchase15,000$1.30
Mar 3, 2025Selhorn Ryan J · officer: Chief Financial OfficerM-Exempt105$0.00
Jan 2, 2025PYSZCZYMUKA GREG · officer: Chief Commercial OfficerM-Exempt208$0.00
Nov 13, 2024Selhorn Ryan J · officer: Chief Financial OfficerA-Award14,000$0.00
Nov 8, 2024LIU VIVIAN H · directorA-Award1,500$0.00
Nov 8, 2024Disbrow Joshua R. · director, officer: Chief Executive OfficerA-Award38,000$1.84
Nov 8, 2024Donofrio John Jr. · directorA-Award1,500$0.00
Institutional positioning

13F filings over the trailing two quarters

New 7Increased 10Reduced 6Sold out 36
FilerActionSharesFiled
NANTAHALA CAPITAL MANAGEMENT, LLCUnchanged1,086,812May 15, 2026
STONEPINE CAPITAL MANAGEMENT, LLCReduced792,289May 14, 2026
AWM INVESTMENT COMPANY, INC.Unchanged619,574May 15, 2026
DIADEMA PARTNERS LPIncreased353,077May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position261,146May 15, 2026
CROWN ADVISORS MANAGEMENT, INC.New Position145,000May 8, 2026
TWO SIGMA INVESTMENTS, LPIncreased121,973May 15, 2026
RENAISSANCE TECHNOLOGIES LLCIncreased93,723May 14, 2026
PERSISTENT ASSET PARTNERS LTDIncreased92,897May 12, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased92,636May 15, 2026
ARETE WEALTH ADVISORS, LLCNew Position49,549May 18, 2026
CITADEL ADVISORS LLCIncreased49,414Sep 2, 2026
VANGUARD FIDUCIARY TRUST CONew Position47,048May 8, 2026
DIMENSIONAL FUND ADVISORS LPIncreased43,585May 7, 2026
CITADEL ADVISORS LLCIncreased36,841May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 30, 2026